Since 1965, Colorado has been screening newborns for inherited disorders.
Screening began with only one test, Phenylketonuria (PKU), and has expanded over the years to include screening for 30 disorders.
In 2006, the Newborn Screening laboratory added Tandem Mass Spectrometry testing, enabling the lab to detect 23 additional metabolic disorders including amino acidemias, organic acidemias, and disorders of fatty acid oxidation in newborn babies.
Screening allows for early diagnosis and treatment that prevents mental retardation, developmental delays, organ damage and, in some cases, death.
At the present time, there are no federal laws which regulate newborn screening programs. Each state adopts its own newborn screening laws, determines policies and procedures related to screening and operates the newborn screening programs within each individual state. As such, the number of conditions that each state screens for varies widely.